首页> 外国专利> PROCESSES TO PREPARE A COMPOUND, OR A PHARMACEUTICALLY ACCEPTABLE SALT FROM THE SAME OR A HYDRATE OF THE SAME, AND TO PREPARE 1.5 COMPOSITE HYDRATE, COMPOUND, PHARMACEUTICAL COMPOSITION, AND, 1.5 HYDRATE (SESQUI-HYDRATE) COMPOUND.

PROCESSES TO PREPARE A COMPOUND, OR A PHARMACEUTICALLY ACCEPTABLE SALT FROM THE SAME OR A HYDRATE OF THE SAME, AND TO PREPARE 1.5 COMPOSITE HYDRATE, COMPOUND, PHARMACEUTICAL COMPOSITION, AND, 1.5 HYDRATE (SESQUI-HYDRATE) COMPOUND.

机译:从相同或相同的水合物中制备化合物或可药用盐的方法,并制备1.5的复合水合物,化合物,药物成分和1.5的水合物(均水合物)。

摘要

the present invention relates to: a new method for preparing a heterocyclic derivative compound of chemical formula i below; a new intermediate compound used in the preparation method; a composition for treating or preventing hyperuricacidemia, gout, nephritis, chronic renal failure, nephrolyte, uremia, urolithiasis or a disease related to uric acid, the composition containing the compound of chemical formula i in a dose greater than 2 mg and equal to or less than 10 mg and being administered orally once a day; and a hydrate 1.5 of the hydrochloride of the new compound of chemical formula i.
机译:本发明涉及:一种制备以下化学式i的杂环衍生物的新方法;制备方法中使用的新型中间体化合物;用于治疗或预防高尿酸血症,痛风,肾炎,慢性肾功能衰竭,肾液,尿毒症,尿石症或与尿酸有关的疾病的组合物,该组合物包含化学式i的化合物的剂量大于2mg且等于或小于少于10毫克,每天口服一次;和化学式i的新化合物的盐酸盐的水合物1.5。

著录项

  • 公开/公告号BR112019024253A2

    专利类型

  • 公开/公告日2020-06-02

    原文格式PDF

  • 申请/专利权人 JW PHARMACEUTICAL CORPORATION;

    申请/专利号BR20191124253

  • 发明设计人 DO KYU PYUN;KYOUNG JIN OO;

    申请日2018-05-24

  • 分类号C07D498/04;A61K9/20;A61K31/5383;

  • 国家 BR

  • 入库时间 2022-08-21 11:18:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号